ハンガリー製薬会社HYDファーマ、がん治療薬臨床試験へ
ハンガリーの製薬会社HYDファーマはこのほど、開発中のがん治療薬の第1相試験が完了したことを明らかにした。投資額は2億5,000万フォリント。近く第2相の臨床検査に着手する計画で、数億フォリント規模を投資する。現地通信社 […]
ハンガリーの製薬会社HYDファーマはこのほど、開発中のがん治療薬の第1相試験が完了したことを明らかにした。投資額は2億5,000万フォリント。近く第2相の臨床検査に着手する計画で、数億フォリント規模を投資する。現地通信社 […]
Cookie | 期間 | 説明 |
---|---|---|
cookielawinfo-checbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |